| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FKBP15 PTPRC DCDC1 CLASP1 CLIP2 CENPE KTN1 PHACTR4 CEP57L1 MYH15 DMD CCDC181 CAP1 PHACTR1 | 1.79e-06 | 1099 | 57 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | kinetochore binding | 1.19e-04 | 6 | 57 | 2 | GO:0043515 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.40e-04 | 308 | 57 | 6 | GO:0008017 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 5.19e-04 | 12 | 57 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 7.13e-04 | 14 | 57 | 2 | GO:0036312 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 1.06e-03 | 17 | 57 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 1.06e-03 | 17 | 57 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | lamin binding | 1.33e-03 | 19 | 57 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.35e-03 | 428 | 57 | 6 | GO:0015631 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 1.78e-03 | 22 | 57 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | actin binding | 2.38e-03 | 479 | 57 | 6 | GO:0003779 | |
| GeneOntologyCellularComponent | mitotic spindle | 2.37e-04 | 201 | 58 | 5 | GO:0072686 | |
| GeneOntologyCellularComponent | lamellipodium | 4.40e-04 | 230 | 58 | 5 | GO:0030027 | |
| GeneOntologyCellularComponent | microtubule | 6.57e-04 | 533 | 58 | 7 | GO:0005874 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 7.74e-04 | 899 | 58 | 9 | GO:0099513 | |
| Domain | RPEL | 1.71e-04 | 7 | 54 | 2 | PS51073 | |
| Domain | RPEL | 1.71e-04 | 7 | 54 | 2 | PF02755 | |
| Domain | RPEL | 1.71e-04 | 7 | 54 | 2 | SM00707 | |
| Domain | RPEL_repeat | 1.71e-04 | 7 | 54 | 2 | IPR004018 | |
| Domain | RCC1 | 1.51e-03 | 20 | 54 | 2 | PF00415 | |
| Domain | RCC1_1 | 1.66e-03 | 21 | 54 | 2 | PS00625 | |
| Domain | RCC1_2 | 1.66e-03 | 21 | 54 | 2 | PS00626 | |
| Domain | RCC1_3 | 1.66e-03 | 21 | 54 | 2 | PS50012 | |
| Domain | Reg_chr_condens | 1.83e-03 | 22 | 54 | 2 | IPR000408 | |
| Domain | - | 1.83e-03 | 22 | 54 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 2.00e-03 | 23 | 54 | 2 | IPR009091 | |
| Domain | PROTEIN_KINASE_TYR | 2.78e-03 | 97 | 54 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.78e-03 | 97 | 54 | 3 | IPR008266 | |
| Domain | PTPc | 4.85e-03 | 36 | 54 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.68e-03 | 39 | 54 | 2 | PS50055 | |
| Domain | PTPase_domain | 6.26e-03 | 41 | 54 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 6.26e-03 | 41 | 54 | 2 | PF00102 | |
| Domain | Znf_C2H2-like | 7.70e-03 | 796 | 54 | 7 | IPR015880 | |
| Domain | Znf_C2H2 | 8.17e-03 | 805 | 54 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 8.33e-03 | 808 | 54 | 7 | SM00355 | |
| Domain | VWA | 1.14e-02 | 56 | 54 | 2 | PF00092 | |
| Pathway | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING | 2.07e-04 | 8 | 39 | 2 | M27351 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.42e-04 | 111 | 39 | 4 | M27673 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.96e-04 | 117 | 39 | 4 | MM15387 | |
| Pubmed | 4.87e-07 | 421 | 58 | 8 | 36976175 | ||
| Pubmed | 1.10e-06 | 322 | 58 | 7 | 26514267 | ||
| Pubmed | 2.49e-06 | 708 | 58 | 9 | 39231216 | ||
| Pubmed | Myosin gene mutation correlates with anatomical changes in the human lineage. | 2.73e-06 | 2 | 58 | 2 | 15042088 | |
| Pubmed | Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer. | 2.73e-06 | 2 | 58 | 2 | 17378731 | |
| Pubmed | 3.51e-06 | 549 | 58 | 8 | 38280479 | ||
| Pubmed | RPGRIP1 SPAG1 STXBP2 ATRX KTN1 CNTRL UBR4 KRT20 MYH15 DMD AKAP8L GOLGB1 | 3.75e-06 | 1442 | 58 | 12 | 35575683 | |
| Pubmed | FKBP15 STRAP CLASP1 CLIP2 CENPE KTN1 UBR4 CTNND1 GOLGB1 PHACTR1 | 3.96e-06 | 963 | 58 | 10 | 28671696 | |
| Pubmed | 5.14e-06 | 263 | 58 | 6 | 34702444 | ||
| Pubmed | Evolution of sarcomeric myosin heavy chain genes: evidence from fish. | 8.19e-06 | 3 | 58 | 2 | 15014174 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22307330 | ||
| Pubmed | PTPRC ATRX AHCTF1 CNTRL CEP57L1 ZNF507 ALS2 PEAK1 GOLGB1 PHACTR1 | 1.11e-05 | 1084 | 58 | 10 | 11544199 | |
| Pubmed | 1.62e-05 | 486 | 58 | 7 | 20936779 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 11919279 | ||
| Pubmed | Human MPS1 kinase is required for mitotic arrest induced by the loss of CENP-E from kinetochores. | 1.64e-05 | 4 | 58 | 2 | 12686615 | |
| Pubmed | ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice. | 1.64e-05 | 4 | 58 | 2 | 12414501 | |
| Pubmed | 1.90e-05 | 94 | 58 | 4 | 32062451 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 18523268 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 10477750 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 11290329 | ||
| Pubmed | 2.84e-05 | 733 | 58 | 8 | 34672954 | ||
| Pubmed | ATRX AHCTF1 KTN1 UBR4 PHACTR4 EFR3B PEAK1 CTNND1 GOLGB1 HERC5 FAM83B | 3.01e-05 | 1487 | 58 | 11 | 33957083 | |
| Pubmed | ATRX CLASP1 ZNF277 PHF3 CDC16 AHCTF1 KTN1 AKAP8L GOLGB1 FAM83B IWS1 | 3.20e-05 | 1497 | 58 | 11 | 31527615 | |
| Pubmed | Development of a screening set for new (CAG/CTG)n dynamic mutations. | 4.08e-05 | 6 | 58 | 2 | 8786123 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.17e-05 | 774 | 58 | 8 | 15302935 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 4.22e-05 | 565 | 58 | 7 | 25468996 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.43e-05 | 588 | 58 | 7 | 38580884 | |
| Pubmed | Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. | 5.71e-05 | 7 | 58 | 2 | 15107502 | |
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 1454056 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 12376545 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 10330270 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 30538245 | ||
| Pubmed | Different expression patterns of Phactr family members in normal and injured mouse brain. | 5.71e-05 | 7 | 58 | 2 | 22766235 | |
| Pubmed | The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn). | 5.71e-05 | 7 | 58 | 2 | 12370829 | |
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 1932742 | ||
| Pubmed | Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. | 7.60e-05 | 8 | 58 | 2 | 15616565 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 8.21e-05 | 853 | 58 | 8 | 28718761 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 8.76e-05 | 861 | 58 | 8 | 36931259 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 39424804 | ||
| Pubmed | Msx1 and Msx2 are expressed in sub-populations of vascular smooth muscle cells. | 9.77e-05 | 9 | 58 | 2 | 18627106 | |
| Pubmed | 1.03e-04 | 54 | 58 | 3 | 36237976 | ||
| Pubmed | 1.06e-04 | 1139 | 58 | 9 | 36417873 | ||
| Pubmed | 1.09e-04 | 55 | 58 | 3 | 18448421 | ||
| Pubmed | 1.20e-04 | 288 | 58 | 5 | 23383273 | ||
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 26642357 | ||
| Pubmed | Endocardially Derived Macrophages Are Essential for Valvular Remodeling. | 1.22e-04 | 10 | 58 | 2 | 30799229 | |
| Pubmed | 1.28e-04 | 1168 | 58 | 9 | 19946888 | ||
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 22046273 | ||
| Pubmed | Gene expression analysis of myeloid and lymphoid lineage markers during mouse haematopoiesis. | 1.49e-04 | 11 | 58 | 2 | 16925795 | |
| Pubmed | c-kit+ cells minimally contribute cardiomyocytes to the heart. | 1.49e-04 | 11 | 58 | 2 | 24805242 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.53e-04 | 934 | 58 | 8 | 33916271 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.82e-04 | 168 | 58 | 4 | 30631154 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.90e-04 | 170 | 58 | 4 | 23314748 | |
| Pubmed | Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function. | 2.11e-04 | 13 | 58 | 2 | 29114040 | |
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 10981960 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.62e-04 | 759 | 58 | 7 | 35915203 | |
| Pubmed | 2.73e-04 | 538 | 58 | 6 | 28524877 | ||
| Pubmed | 3.23e-04 | 16 | 58 | 2 | 8875997 | ||
| Pubmed | Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex. | 3.23e-04 | 16 | 58 | 2 | 25425146 | |
| Pubmed | 3.36e-04 | 1049 | 58 | 8 | 27880917 | ||
| Pubmed | 3.38e-04 | 360 | 58 | 5 | 33111431 | ||
| Pubmed | 3.66e-04 | 17 | 58 | 2 | 19690890 | ||
| Pubmed | Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control. | 3.66e-04 | 17 | 58 | 2 | 29033132 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.14e-04 | 582 | 58 | 6 | 20467437 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 4.17e-04 | 377 | 58 | 5 | 38117590 | |
| Pubmed | 4.18e-04 | 1371 | 58 | 9 | 36244648 | ||
| Pubmed | 4.25e-04 | 210 | 58 | 4 | 16565220 | ||
| Pubmed | 4.49e-04 | 591 | 58 | 6 | 15231748 | ||
| Pubmed | 4.59e-04 | 19 | 58 | 2 | 17609112 | ||
| Pubmed | 4.89e-04 | 218 | 58 | 4 | 19460752 | ||
| Pubmed | 5.06e-04 | 847 | 58 | 7 | 35850772 | ||
| Pubmed | 5.39e-04 | 399 | 58 | 5 | 37536630 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 6.07e-04 | 231 | 58 | 4 | 16452087 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 6.34e-04 | 1155 | 58 | 8 | 20360068 | |
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 6.72e-04 | 102 | 58 | 3 | 20508983 | |
| Pubmed | 6.76e-04 | 23 | 58 | 2 | 25523391 | ||
| Pubmed | Yolk-sac-derived macrophages regulate fetal testis vascularization and morphogenesis. | 7.37e-04 | 24 | 58 | 2 | 24912173 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 7.80e-04 | 247 | 58 | 4 | 32989298 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 8.37e-04 | 440 | 58 | 5 | 34244565 | |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 8.59e-04 | 111 | 58 | 3 | 22558309 | |
| Pubmed | 9.34e-04 | 27 | 58 | 2 | 23001562 | ||
| Pubmed | 9.76e-04 | 686 | 58 | 6 | 29987050 | ||
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 1.00e-03 | 28 | 58 | 2 | 24462114 | |
| Pubmed | 1.08e-03 | 29 | 58 | 2 | 34007995 | ||
| Pubmed | 1.09e-03 | 467 | 58 | 5 | 30194290 | ||
| Pubmed | Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. | 1.23e-03 | 31 | 58 | 2 | 14684825 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 1.26e-03 | 1284 | 58 | 8 | 17353931 | |
| Pubmed | Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome. | 1.31e-03 | 32 | 58 | 2 | 20056645 | |
| Pubmed | Murine txk: a protein tyrosine kinase gene regulated by T cell activation. | 1.31e-03 | 32 | 58 | 2 | 7542761 | |
| Pubmed | 1.37e-03 | 288 | 58 | 4 | 38496616 | ||
| Pubmed | 1.39e-03 | 493 | 58 | 5 | 15368895 | ||
| Pubmed | 1.39e-03 | 1007 | 58 | 7 | 34597346 | ||
| Pubmed | 1.40e-03 | 33 | 58 | 2 | 36922518 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.44e-03 | 497 | 58 | 5 | 36774506 | |
| Pubmed | 1.45e-03 | 1014 | 58 | 7 | 32416067 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.45e-03 | 498 | 58 | 5 | 36634849 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 1.46e-03 | 742 | 58 | 6 | 26871637 | |
| Pubmed | 1.53e-03 | 504 | 58 | 5 | 34432599 | ||
| Pubmed | 1.55e-03 | 1327 | 58 | 8 | 32694731 | ||
| Pubmed | 1.55e-03 | 506 | 58 | 5 | 30890647 | ||
| Interaction | PTPRA interactions | 7.56e-06 | 164 | 58 | 6 | int:PTPRA | |
| Interaction | WWTR1 interactions | 2.65e-05 | 422 | 58 | 8 | int:WWTR1 | |
| Interaction | STX4 interactions | 2.93e-05 | 428 | 58 | 8 | int:STX4 | |
| Interaction | EPHA2 interactions | CSF1R PHACTR4 EFR3B PEAK1 CTNND1 DMD AKAP8L RYK GOLGB1 FAM83B | 3.48e-05 | 719 | 58 | 10 | int:EPHA2 |
| Interaction | MTNR1B interactions | 4.32e-05 | 135 | 58 | 5 | int:MTNR1B | |
| Interaction | AFDN interactions | 4.61e-05 | 333 | 58 | 7 | int:AFDN | |
| Interaction | LAMP1 interactions | 8.63e-05 | 644 | 58 | 9 | int:LAMP1 | |
| GeneFamily | Phosphatase and actin regulators | 2.18e-05 | 4 | 35 | 2 | 679 | |
| GeneFamily | Myosin heavy chains | 3.76e-04 | 15 | 35 | 2 | 1098 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 7.47e-04 | 21 | 35 | 2 | 813 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.71e-03 | 40 | 35 | 2 | 321 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 4.72e-03 | 53 | 35 | 2 | 103 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.10e-03 | 181 | 35 | 3 | 694 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ATRX CENPE KTN1 CEP57L1 ZNF507 ZNF407 DMD AKAP8L GOLGB1 IWS1 | 5.96e-06 | 629 | 57 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.32e-07 | 199 | 58 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 11.5-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 2.32e-07 | 199 | 58 | 6 | dd61854de202c805100bad58f1ce08c3bd04bb58 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-07 | 200 | 58 | 6 | 7076b0db66c8f90c8f9ccfbc8bc0dcc82b15e5f3 | |
| ToppCell | 11.5-Distal-Immune|Distal / Age, Tissue, Lineage and Cell class | 2.39e-07 | 200 | 58 | 6 | c9ed06ae7a8f5a88578c8269d762d8739ae79c7f | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.39e-07 | 200 | 58 | 6 | fe7f8b04067b6680b69c8523f0fa514ef97207e2 | |
| ToppCell | 11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 3.84e-06 | 181 | 58 | 5 | 193ee02f547a218b2fc13e1174ea4cff4f8a3450 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 184 | 58 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.39e-06 | 194 | 58 | 5 | de9c7c602d886d0cd8bbd1d7e7744f84df951238 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.39e-06 | 194 | 58 | 5 | 49441ca0a8fa34cb847fecbb4b809dd01d879ebb | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.39e-06 | 194 | 58 | 5 | 16c6fcbd36d473b883fb5361caca86eb134767ab | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.52e-06 | 195 | 58 | 5 | 01da7115e38c280fb0baff2032b62bdb609bad5e | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.66e-06 | 196 | 58 | 5 | b904f3a6d6a93e149f5a1b34b6adad5c7894754d | |
| ToppCell | BL-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.66e-06 | 196 | 58 | 5 | f64d7fed31e418c55fe946744d78c3cbecec9bbf | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-06 | 197 | 58 | 5 | b4f6501c266328439cba4f174e594a6a04a252a1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-06 | 197 | 58 | 5 | c6e977adb1248957d31300312310e08238b64236 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-06 | 197 | 58 | 5 | d568354aff89ac84dd06360f19100ef578a041ed | |
| ToppCell | critical-Myeloid|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.95e-06 | 198 | 58 | 5 | a5807517f8ca93b77f49f5787fd9036178b8fc2a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-06 | 198 | 58 | 5 | 7015b9f5ead65937e056d746340d44d0655d6a3e | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 5.95e-06 | 198 | 58 | 5 | 0e4aa6c7d74c5b1bb26996df1be3d58f998d18ac | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.95e-06 | 198 | 58 | 5 | 79c8ab15e73f727c5e110ab9eab3ccb5edf9f714 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-06 | 198 | 58 | 5 | 4ba72ba1f0cebc93053aae72d763c33e155b6fa4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-06 | 198 | 58 | 5 | 6edf6c547e8a3aa2b23df4662bf59ed38caa9e5e | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 6.10e-06 | 199 | 58 | 5 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-06 | 199 | 58 | 5 | e12cea071e46436835cc22fe7badcbe878a1305b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-06 | 199 | 58 | 5 | 2ff5007b971c6fca9a9ef433e257739f0322a2a5 | |
| ToppCell | critical|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.10e-06 | 199 | 58 | 5 | 16c55cb8a0e740342009965f0eddfb0ed2858fab | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-06 | 199 | 58 | 5 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.10e-06 | 199 | 58 | 5 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.10e-06 | 199 | 58 | 5 | 76aab03a51681f0ce3369887cf71a884b0998ec5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-06 | 199 | 58 | 5 | 0a9783808528bc4c6d797d849a9177330c8fb867 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.10e-06 | 199 | 58 | 5 | 7227e6be56e9f333ee143e1418d22de32a4ca66a | |
| ToppCell | NS-critical|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.10e-06 | 199 | 58 | 5 | f7c14dc9a9e659f89352dccf8954d6cbada011ab | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | 700960201ae0df2c79e2907f5a0f95d73f8034fe | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | 83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.25e-06 | 200 | 58 | 5 | 47abc2ebf5d6575af59aa044b584acf63a463bbb | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | d39bf03817b76c9dfcbcd868341b51bb8601ea9b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.25e-06 | 200 | 58 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.25e-06 | 200 | 58 | 5 | 8fd88dfc6e08e0186fc0f061526ad98a3b00bc31 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | d237cf947d6768b022d18211e14af4adb4990708 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.25e-06 | 200 | 58 | 5 | fd1b6db3c62f5a205b769ba0e61433dae6285b67 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-06 | 200 | 58 | 5 | 26251ed8c7fa7e87973d6f59bd398c88ad025395 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.25e-06 | 200 | 58 | 5 | 0b7573ec4e9c67c7d11dd8f5011a70bade30e930 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | 0855ebb10b925664aa5cf813d97e97683c46180d | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.26e-05 | 149 | 58 | 4 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 153 | 58 | 4 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 153 | 58 | 4 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 162 | 58 | 4 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | facs-Heart-RA-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 163 | 58 | 4 | da7ab9582e8070b07ca628a6394c86684d37d6ef | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.19e-05 | 164 | 58 | 4 | 6a113191ea91d103d21c5f056b1950217688ea26 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.34e-05 | 165 | 58 | 4 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.34e-05 | 165 | 58 | 4 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 6.64e-05 | 167 | 58 | 4 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 167 | 58 | 4 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 167 | 58 | 4 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 167 | 58 | 4 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 170 | 58 | 4 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | facs-Heart-LV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 4eaa22040e475100061475123aefa32b56481464 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 60041b2e57e958f300a5bc76851705c8baf297c2 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 793dde64f5517538b66de5f461a445c4ad6dd7b3 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.96e-05 | 175 | 58 | 4 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.14e-05 | 176 | 58 | 4 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-05 | 177 | 58 | 4 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-05 | 177 | 58 | 4 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-05 | 178 | 58 | 4 | 8184a2b9872f7ca12a9823535de485e841aeffb1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.51e-05 | 178 | 58 | 4 | aa9f68a66e292f331faef881bbd0d028f0f2b0c5 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-05 | 180 | 58 | 4 | 97241f62ee133dcb0d4855ffda5dd1349de9f7b2 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-05 | 180 | 58 | 4 | 41896546cd1cc458e08c0d4e19aa4860e5d4fcd6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.07e-05 | 181 | 58 | 4 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | Control-Myeloid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-05 | 181 | 58 | 4 | 25170e5285996cc80337d5f86a0255569861ae77 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.27e-05 | 182 | 58 | 4 | d5d6bc16458bc665e7ad6669040d79f73f640044 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 182 | 58 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.27e-05 | 182 | 58 | 4 | 0b59ead4bb4486c7ec2ee90b94ee3a09905612c5 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.27e-05 | 182 | 58 | 4 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.27e-05 | 182 | 58 | 4 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.47e-05 | 183 | 58 | 4 | 24679153b654c148dbd572e9013c0a6e58718ada | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-05 | 183 | 58 | 4 | b12b89debc9dd6396188bc8fe44f54c01c560966 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-05 | 183 | 58 | 4 | 19cc0009f5332b6e4d4274df123eebbfc80b669a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.67e-05 | 184 | 58 | 4 | d7f348aa8901d819c68da20728b9238407bcdca9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.67e-05 | 184 | 58 | 4 | b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 9.87e-05 | 185 | 58 | 4 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 185 | 58 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 186 | 58 | 4 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 186 | 58 | 4 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 186 | 58 | 4 | 0859737021747518731aa67fe181d4ca4fdc0721 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 186 | 58 | 4 | be50f5c7f32b3126442ebff1e7d38aa78b6e4e71 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.01e-04 | 186 | 58 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.03e-04 | 187 | 58 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 188 | 58 | 4 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.05e-04 | 188 | 58 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Monocytes-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-04 | 188 | 58 | 4 | 756375cf9c9cccc4fb4a7f5e4756fa3fc36a7892 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 188 | 58 | 4 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 188 | 58 | 4 | 239bec13476dd43bebc2c6eba8d1fe35f2744673 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 189 | 58 | 4 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.07e-04 | 189 | 58 | 4 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 189 | 58 | 4 | a438c64a893d43f781ede42e1c7b615b74dc76ef | |
| ToppCell | Monocytes-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.07e-04 | 189 | 58 | 4 | 22d08c7dde697f385100f72e009eeac8d19d329d | |
| Disease | migraine without aura, susceptibility to, 4, systolic blood pressure | 2.12e-05 | 4 | 56 | 2 | EFO_0006335, MONDO_0011847 | |
| Disease | migraine without aura | 3.52e-05 | 5 | 56 | 2 | MONDO_0100431 | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 1.26e-04 | 9 | 56 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | magnesium measurement | 2.72e-04 | 66 | 56 | 3 | EFO_0004845 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.97e-04 | 75 | 56 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | lung small cell carcinoma (is_marker_for) | 4.17e-04 | 16 | 56 | 2 | DOID:5409 (is_marker_for) | |
| Disease | migraine without aura, susceptibility to, 4 | 4.17e-04 | 16 | 56 | 2 | MONDO_0011847 | |
| Disease | cervical artery dissection | 4.72e-04 | 17 | 56 | 2 | EFO_1000059 | |
| Disease | migraine disorder, systolic blood pressure | 5.31e-04 | 18 | 56 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | Malignant neoplasm of breast | 9.04e-04 | 1074 | 56 | 8 | C0006142 | |
| Disease | migraine disorder, pulse pressure measurement | 1.12e-03 | 26 | 56 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 1.30e-03 | 28 | 56 | 2 | DOID:8466 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LMTELEIEKSLKHHE | 1401 | Q7Z7A1 | |
| TMTDKEDHVIISDSH | 241 | Q96Q42 | |
| SITHALKHVSDDMKT | 266 | Q01518 | |
| HDLETAMHVKEKEAL | 671 | Q9UDT6 | |
| DLTSHEISLEEMKKH | 1416 | P11532 | |
| LKSHIKEELMHGEEA | 401 | Q6ZUJ8 | |
| EDEMASHLDSKFHKE | 401 | Q9ULX6 | |
| KHTTEHEMSILKKSL | 336 | Q8WWL7 | |
| HEAEKEDSADKVMSH | 321 | Q7Z6M1 | |
| HSSDSEEEEHKKQKM | 361 | Q96ST2 | |
| EKVILSMTAKEHHKE | 421 | M0R2J8 | |
| ELDVSSLEKHLQTMH | 401 | P23469 | |
| ALHKDIHMATKEVVD | 3301 | Q2LD37 | |
| GTLFHLTKHKTDEME | 506 | Q5BJE1 | |
| EDLLKSSKSMHNVTH | 701 | Q5T0W9 | |
| KKHAHLTDTEIMTLV | 41 | O60925 | |
| IVVESKHDSHMAKER | 371 | A8MUH7 | |
| PKKILSHMTHEVTED | 1041 | Q9H792 | |
| HSSHDDLEIKTKIRM | 151 | Q9Y2G0 | |
| DHLMTKVEELQKHSA | 531 | Q5T1M5 | |
| LSVDVLHEKTHLKGM | 386 | Q8NG66 | |
| KVLEHKLKEADEMHT | 1116 | Q86UP2 | |
| LHENETSHEMKKQTL | 1141 | Q9UKK3 | |
| QSHLSMKESLEHTLE | 301 | P35900 | |
| EFKSSEMEVHEESKH | 681 | Q8IZ21 | |
| KSTEMEVHELSRHLT | 561 | Q9C0D0 | |
| KLESHTSEKELIMIA | 351 | Q9UII4 | |
| DLKENETVMEHTKRH | 51 | Q5TID7 | |
| TSHHMLTAQEEKELL | 171 | Q13042 | |
| EAKLSRKQVDSEHMH | 461 | P46100 | |
| TAHADEKEALMSELK | 621 | P07333 | |
| VHTDMTKDLKEEHLK | 181 | Q8N4T8 | |
| HQELLKQMKETESHS | 341 | Q8IYX8 | |
| LHSVSEERTDEMTHK | 2061 | Q8WYP5 | |
| HKDKAKTADVESTMH | 2786 | Q8NDH2 | |
| HLHSMKRIELDDSIS | 251 | P34925 | |
| LENSLHEAKESAMHK | 2386 | Q02224 | |
| HEAKESAMHKESKII | 2391 | Q02224 | |
| KMEIVDHALHALTDE | 486 | O60716 | |
| KEMIHLSFKVSHSDK | 56 | Q5VZ72 | |
| DLTKHHSLIKAEIMG | 451 | Q6ZRF8 | |
| QHEEEEMTLSHSALK | 1056 | Q96KN7 | |
| MEDHDIDVKTKGSHI | 656 | Q9H0K6 | |
| DLHMEEEKLSSLSKA | 1021 | Q9Y2K3 | |
| GDELMTLAHKHIVKT | 91 | Q9Y3F4 | |
| ELTIMKTLEAHKDSH | 1386 | Q7Z460 | |
| EVKHSALSVELHSDM | 2006 | P04275 | |
| IKKEEDKMHFHETET | 106 | Q07617 | |
| LRHMHIADVSKKVTE | 291 | Q15833 | |
| DSKETVKLSHEDDHI | 321 | Q92576 | |
| RKKHVDSMAELTEHV | 356 | Q9H6N6 | |
| TSKENLLDHMKEHEG | 921 | Q8TCN5 | |
| TSKMRHLETHDTDKE | 431 | Q13105 | |
| KIEEHSEDMETHVKT | 161 | Q96AP4 | |
| SEDMETHVKTKHANL | 166 | Q96AP4 | |
| DLRTHMEETKHTSLL | 371 | Q9NRM2 | |
| EFETSSELKEHMKTH | 161 | Q9UL36 | |
| TQMKTHDAESVLKHL | 466 | Q9C0G0 | |
| HHMATLASIIKEVDK | 681 | Q5T4S7 | |
| PLKHELEMSKESEHD | 986 | P08575 | |
| AIHMTKDATKEALHA | 1021 | Q6BDS2 | |
| LEQKHKAEMEEKTSH | 366 | Q14789 |